Zanubrutinib (BGB-3111), a Second-Generation Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase and Its Utility in Treating Chronic Lymphocytic Leukemia

Overview of attention for article published in Drug Design, Development and Therapy, March 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (59th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

Zanubrutinib (BGB-3111), a second-generation selective coval | DDDT

User HighYield, 06 Mar 2021